nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSK—skull—pharynx cancer	0.0587	0.122	CbGeAlD
Boceprevir—CTSV—Activation of Matrix Metalloproteinases—MMP8—pharynx cancer	0.0538	0.104	CbGpPWpGaD
Boceprevir—CMA1—Activation of Matrix Metalloproteinases—MMP8—pharynx cancer	0.05	0.0968	CbGpPWpGaD
Boceprevir—CTSL—Collagen degradation—MMP8—pharynx cancer	0.0469	0.0907	CbGpPWpGaD
Boceprevir—CTSK—Activation of Matrix Metalloproteinases—MMP8—pharynx cancer	0.0446	0.0862	CbGpPWpGaD
Boceprevir—CTSK—Collagen degradation—MMP8—pharynx cancer	0.0389	0.0752	CbGpPWpGaD
Boceprevir—CTSL—mouth—pharynx cancer	0.027	0.0559	CbGeAlD
Boceprevir—CTSL—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0237	0.0459	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0237	0.0459	CbGpPWpGaD
Boceprevir—CTSL—neck—pharynx cancer	0.0231	0.0478	CbGeAlD
Boceprevir—CMA1—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0221	0.0427	CbGpPWpGaD
Boceprevir—CTSK—mouth—pharynx cancer	0.0203	0.0421	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0197	0.0381	CbGpPWpGaD
Boceprevir—CTSL—parotid gland—pharynx cancer	0.0188	0.0389	CbGeAlD
Boceprevir—CTSL—saliva-secreting gland—pharynx cancer	0.018	0.0373	CbGeAlD
Boceprevir—CTSS—mouth—pharynx cancer	0.0178	0.0369	CbGeAlD
Boceprevir—CTSV—trachea—pharynx cancer	0.017	0.0352	CbGeAlD
Boceprevir—CTSS—Degradation of the extracellular matrix—MMP8—pharynx cancer	0.0162	0.0313	CbGpPWpGaD
Boceprevir—CTSL—epithelium—pharynx cancer	0.0157	0.0325	CbGeAlD
Boceprevir—CTSS—neck—pharynx cancer	0.0152	0.0315	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—pharynx cancer	0.0148	0.0306	CbGeAlD
Boceprevir—CTSK—parotid gland—pharynx cancer	0.0142	0.0293	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—pharynx cancer	0.0141	0.0293	CbGeAlD
Boceprevir—CTSL—trachea—pharynx cancer	0.0139	0.0287	CbGeAlD
Boceprevir—CTSK—saliva-secreting gland—pharynx cancer	0.0136	0.0281	CbGeAlD
Boceprevir—CTSV—spinal cord—pharynx cancer	0.0134	0.0278	CbGeAlD
Boceprevir—CTSS—parotid gland—pharynx cancer	0.0124	0.0257	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—pharynx cancer	0.0121	0.025	CbGeAlD
Boceprevir—CTSV—head—pharynx cancer	0.0119	0.0247	CbGeAlD
Boceprevir—CTSS—saliva-secreting gland—pharynx cancer	0.0119	0.0246	CbGeAlD
Boceprevir—CTSL—spinal cord—pharynx cancer	0.011	0.0227	CbGeAlD
Boceprevir—CTSK—trachea—pharynx cancer	0.0105	0.0217	CbGeAlD
Boceprevir—CTSL—Extracellular matrix organization—MMP8—pharynx cancer	0.00995	0.0192	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MMP8—pharynx cancer	0.00995	0.0192	CbGpPWpGaD
Boceprevir—CTSL—head—pharynx cancer	0.00974	0.0202	CbGeAlD
Boceprevir—CMA1—Extracellular matrix organization—MMP8—pharynx cancer	0.00925	0.0179	CbGpPWpGaD
Boceprevir—CTSS—trachea—pharynx cancer	0.00916	0.019	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—pharynx cancer	0.00911	0.0189	CbGeAlD
Boceprevir—CTSK—spinal cord—pharynx cancer	0.00826	0.0171	CbGeAlD
Boceprevir—CTSK—Extracellular matrix organization—MMP8—pharynx cancer	0.00824	0.0159	CbGpPWpGaD
Boceprevir—CTSS—lymphoid tissue—pharynx cancer	0.00798	0.0165	CbGeAlD
Boceprevir—CMA1—lymph node—pharynx cancer	0.00797	0.0165	CbGeAlD
Boceprevir—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.00796	0.0154	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00745	0.0144	CbGpPWpGaD
Boceprevir—CTSL—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00745	0.0144	CbGpPWpGaD
Boceprevir—CTSK—head—pharynx cancer	0.00734	0.0152	CbGeAlD
Boceprevir—CTSS—spinal cord—pharynx cancer	0.00724	0.015	CbGeAlD
Boceprevir—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.00698	0.0135	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00693	0.0134	CbGpPWpGaD
Boceprevir—CTSL—lymph node—pharynx cancer	0.00682	0.0141	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—MMP8—pharynx cancer	0.00679	0.0131	CbGpPWpGaD
Boceprevir—CTSS—head—pharynx cancer	0.00643	0.0133	CbGeAlD
Boceprevir—CTSK—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00617	0.0119	CbGpPWpGaD
Boceprevir—CTSK—lymph node—pharynx cancer	0.00514	0.0106	CbGeAlD
Boceprevir—CTSS—Degradation of the extracellular matrix—CDH1—pharynx cancer	0.00508	0.00983	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00482	0.00933	CbGpPWpGaD
Boceprevir—CTSS—lymph node—pharynx cancer	0.0045	0.00932	CbGeAlD
Boceprevir—CMA1—Metabolism of proteins—B4GALT5—pharynx cancer	0.00444	0.0086	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00423	0.00818	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—CDH1—pharynx cancer	0.00312	0.00604	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—CDH1—pharynx cancer	0.00312	0.00604	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—CDH1—pharynx cancer	0.0029	0.00561	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD79A—pharynx cancer	0.00288	0.00557	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD79A—pharynx cancer	0.00288	0.00557	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00283	0.00548	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—EGFR—pharynx cancer	0.0028	0.00542	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—CDH1—pharynx cancer	0.00259	0.005	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00256	0.00496	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD79A—pharynx cancer	0.00239	0.00461	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00225	0.00435	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00224	0.00434	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—CDH1—pharynx cancer	0.00213	0.00412	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00197	0.0038	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—pharynx cancer	0.00196	0.0038	CbGpPWpGaD
Boceprevir—ABCB1—epithelium—pharynx cancer	0.00183	0.00378	CbGeAlD
Boceprevir—CTSL—Immune System—CD79A—pharynx cancer	0.00175	0.00338	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—pharynx cancer	0.00175	0.00338	CbGpPWpGaD
Boceprevir—ABCB1—trachea—pharynx cancer	0.00162	0.00335	CbGeAlD
Boceprevir—CTSL—Adaptive Immune System—CDH1—pharynx cancer	0.0016	0.0031	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CDH1—pharynx cancer	0.0016	0.0031	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD79A—pharynx cancer	0.00145	0.0028	CbGpPWpGaD
Boceprevir—ABCB1—lymphoid tissue—pharynx cancer	0.00141	0.00291	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—CDH1—pharynx cancer	0.00133	0.00257	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00132	0.00255	CbGpPWpGaD
Boceprevir—ABCB1—spinal cord—pharynx cancer	0.00128	0.00264	CbGeAlD
Boceprevir—CTSS—Immune System—CD79A—pharynx cancer	0.00119	0.0023	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00119	0.0023	CbGpPWpGaD
Boceprevir—ABCB1—head—pharynx cancer	0.00113	0.00235	CbGeAlD
Boceprevir—CTSS—Adaptive Immune System—CDH1—pharynx cancer	0.00109	0.00212	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00104	0.00202	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—pharynx cancer	0.000977	0.00189	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EGFR—pharynx cancer	0.000977	0.00189	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDH1—pharynx cancer	0.000973	0.00188	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDH1—pharynx cancer	0.000973	0.00188	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—EGFR—pharynx cancer	0.000938	0.00181	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—pharynx cancer	0.000938	0.00181	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—EGFR—pharynx cancer	0.000809	0.00157	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDH1—pharynx cancer	0.000806	0.00156	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—pharynx cancer	0.000794	0.00164	CbGeAlD
Boceprevir—CTSK—Adaptive Immune System—EGFR—pharynx cancer	0.000777	0.0015	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—pharynx cancer	0.000666	0.00129	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—pharynx cancer	0.000664	0.00128	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—EGFR—pharynx cancer	0.00064	0.00124	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—pharynx cancer	0.000569	0.0011	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—pharynx cancer	0.000569	0.0011	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.000485	0.000937	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—pharynx cancer	0.000471	0.000912	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000438	0.000848	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—pharynx cancer	0.000436	0.000843	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—pharynx cancer	0.000388	0.000751	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000384	0.000743	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000367	0.00071	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000366	0.000707	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—pharynx cancer	0.000342	0.000661	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000339	0.000656	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADH7—pharynx cancer	0.000331	0.00064	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADH1B—pharynx cancer	0.00029	0.000561	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—pharynx cancer	0.000287	0.000555	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000277	0.000536	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000266	0.000514	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000225	0.000436	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000223	0.000432	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000204	0.000394	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000179	0.000346	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000171	0.00033	CbGpPWpGaD
